Menu
Microsoft strongly encourages users to switch to a different browser than Internet Explorer as it no longer meets modern web and security standards. Therefore we cannot guarantee that our site fully works in Internet Explorer. You can use Chrome or Firefox instead.

Neogen Corp. buy melinda

Start price
€28.63
17.11.18 / 50%
Target price
€30.22
22.01.19
Performance (%)
-4.58%
End price
€27.32
22.01.19
Summary
This prediction ended on 22.01.19 with a price of €27.32. With a performance of -4.58%, the BUY prediction by melinda finished with a loss. melinda has 50% into this prediction
Performance without dividends (%)
Name 1w 1m 1y 3y
Neogen Corp. 0.893% 0.893% -27.097% -71.392%
iShares Core DAX® 1.051% -1.833% 12.822% 15.392%
iShares Nasdaq 100 -0.547% -3.738% 40.625% 42.396%
iShares Nikkei 225® -1.778% -8.115% 16.092% 0.891%
iShares S&P 500 0.002% -2.226% 28.387% 41.095%

According to melinda what are the pros and cons of Neogen Corp. for the foreseeable future?

Pros
Could be worthwhile Investment >10% per year
Cons

Comments by melinda for this prediction

In the thread Neogen Corp. diskutieren
Prediction Buy
Perf. (%) -4.58%
Target price 60.434
Change
Ends at 22.01.19

SecteurEquipement, fournitures et distribution médicale Agenda 26/03 Publication de résultats



Métier
Logo Neogen Corporation
Manufactures and markets medical testing kits

Neogen Corp. engages in the development, manufacture, and sale of products dedicated to food and animal safety.

It operates through the following segments: Food Safety, Animal Safety, and Corporate.

The Food Safety segment consists of the development, production and marketing of diagnostic test kits, dehydrated culture media and related products used by food producers and processors to detect harmful natural toxins, foodborne bacteria, allergens, drug residues, and levels of general sanitation.

The Animal Safety segment includes the development, production and marketing of products dedicated to animal safety, including a complete line of consumable products marketed to veterinarians and animal health product distributors.

The Corporate segment refers to the corporate assets, including cash and cash equivalents, marketable securities, current and deferred tax accounts, and overhead expenses not allocated to specific business segments.

The company was founded on June 30, 1981 and is headquartered in Lansing, MI.

Nombre d'employés : 1 546 personnes.



Prediction Buy
Perf. (%) -4.58%
Target price 60.434
Change
Ends at 22.01.19

(Vom Mitglied beendet)

Stopped prediction by melinda for Neogen Corp.

buy
Neogen Corp.

Start price
Target price
Perf. (%)
€35.40
14.12.21
€38.00
14.12.22
-59.89%
15.12.22

Could be worthwhile Investment >10% per year
buy
Neogen Corp.

Start price
Target price
Perf. (%)
€21.34
04.04.17
€22.32
02.06.17
4.72%
02.06.17

Could be worthwhile Investment >10% per year
buy
Neogen Corp.

Start price
Target price
Perf. (%)
€11.09
28.09.13
€11.75
27.11.13
20.15%
27.11.13

Could be worthwhile Investment >10% per year